Log inSign up
Noam Solomon
63 posts
user avatar
Noam Solomon
@NoamSolomon1
CEO and co-founder at Immunai
Tel Aviv
Joined May 2020
80
Following
289
Followers
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Jan 3, 2023
    "The real question is how we can build a machine that is not just as good as scientists, but much, much better" (in doing drug discovery and drug candidate evaluation) It was a pleasure to take part in @HowIBuiltThis podcast with @guyraz
    HIBT Lab! Immunai: Noam Solomon
    podcasts.apple.com
    HIBT Lab! Immunai: Noam Solomon
    Podcast Episode · How I Built This with Guy Raz · December 22, 2022 · 34m
    366
  • user avatar
    Noam Solomon
    @NoamSolomon1
    May 19, 2023
    Joint BCM-Immunai Nature Medicine publication on Anti-GD2 CAR-NKT therapy for Neuroblastoma nature.com/articles/s4159… led by Andras Heczey and Leonid Metelitsa
    Content cover image
    Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim...
    From nature.com
    651
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Apr 23, 2024
    what we see in universities is free hate, not free speech. young students go to universities to seek guidance - they follow you for your advice, your leadership - I ask my fellow professors and scientists to provide a clear moral stand, especially these days, it is so important!
    460
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Feb 11, 2023
    @IdoAmitLab Ido Amit visit at @Immunaitech for our Immunology summit: unlocking immunomics is a group activity! @DahanLab Dan Littman @Satpathology
    user avatar
    IdoAmitLab
    @IdoAmitLab
    Feb 8, 2023
    Inspiring day in Immunai- unfolding the next frontiers of bigdata-driven immunotherapies @DahanLab, @NoamSolomon1, @Immunaitech
    Image
    Image
    Image
    509
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Sep 8, 2022
    If you're in Israel on the 19th, come join us for a stimulating panel on the future of therapeutics!
    Image
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Feb 12, 2021
    Reprogamming immunity with AI-powered single-cell functional genomics! #immunai #genetics #single-cell-biology #engineering #AI
    techcrunch.com
    Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too |...
    Just two years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million.
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Dec 7, 2023
    Thank you @AlbertBourla for your clear stand on what's right and what's wrong!
    user avatar
    Albert Bourla
    @AlbertBourla
    Dec 6, 2023
    I was ashamed to hear the recent testimony of 3 top university presidents. In my personal opinion, it was one of the most despicable moments in the history of U.S. academia. The 3 Presidents were offered numerous opportunities to condemn racist, antisemitic, hate rhetoric and
    Image
    404
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Jun 3, 2020
    Why Viola Ventures invested in Immunai calcalistech.com/ctech/articles…
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Dec 29, 2022
    Nature is about diversity. It took modern civilization millennia to accept basic values and arrive at the understanding that we all deserve the same human rights. Let's not take it for granted, evil will happen when indifference allows it to
    229
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Jun 7, 2023
    "Science is about discovering what is possible, whereas engineering is about making the possible useful"
    user avatar
    VSC
    @VSCPR
    Jun 7, 2023
    In a new #Adrenaline Q+A, @Immunaitech CEO and co-founder @NoamSolomon1 shares his perspective on techbio, finding investors who will let you fail fast, and building a unified team. #Tech #Bio #Entrepreneurship #Startup Learn more: bit.ly/3qzLwwE
    Image
    513
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Oct 9, 2024
    Proud of @Immunaitech new multi-year collaboration with @AstraZeneca builds on our existing work to accelerate oncology drug development by leveraging our AI-powered platforms, AMICA™, and the Immunodynamics Engine (IDE)™
    graphic of immunogloblin antibodies circulating
    AstraZeneca extends AI immuno-oncology R&D pact with Immunai
    From fiercebiotech.com
    177
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Jul 8, 2023
    The therapeutics space is a whole different story. < 10% of drug candidates identified by human experts and validated pre-clinically will eventually receive FDA approval. We must therefore deliver not human-expert parity but a complete paradigm shift.
    Medium
    Engineering-enabled AI
    From medium.com
    292
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Aug 23, 2024
    It was a pleasure hosting @RuthReader at @Immunaitech’s NY office, where we explored AI & drug discovery. Read @politico's Future Pulse newsletter to learn how we’re mapping the immune system to help drugmakers better understand therapies. bit.ly/3yRzIKL
    1K
  • user avatar
    Noam Solomon
    @NoamSolomon1
    Jun 18, 2023
    The immune system is incredibly complex. When we started, people told me it was even infinitely complex. I am a mathematician, and mathematicians like to count complicated things, even different infinities. This is what drew me to the problem
    Image
    Immunai, BCM developing first-in-human cell therapy for neuroblastoma
    From jpost.com
    335

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement